Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Differential Expression of BARD1 Isoforms in Melanoma.
McDougall LI, Powell RM, Ratajska M, Lynch-Sutherland CF, Hossain SM, Wiggins GAR, Harazin-Lechowska A, Cybulska-Stopa B, Motwani J, Macaulay EC, Reid G, Walker LC, Ryś J, Eccles MR. McDougall LI, et al. Among authors: harazin lechowska a. Genes (Basel). 2021 Feb 23;12(2):320. doi: 10.3390/genes12020320. Genes (Basel). 2021. PMID: 33672422 Free PMC article.
Prognostic value of PIK3CA mutation status, PTEN and androgen receptor expression for metastasis-free survival in HER2-positive breast cancer patients treated with trastuzumab in adjuvant setting.
Adamczyk A, Niemiec J, Janecka A, Harazin-Lechowska A, Ambicka A, Grela-Wojewoda A, Domagała-Haduch M, Cedrych I, Majchrzyk K, Kruczak A, Ryś J, Jakubowicz J. Adamczyk A, et al. Pol J Pathol. 2015 Jun;66(2):133-41. doi: 10.5114/pjp.2015.53009. Pol J Pathol. 2015. PMID: 26247526 Free article.
Proteins Involved in HER2 Signalling Pathway, Their Relations and Influence on Metastasis-Free Survival in HER2-Positive Breast Cancer Patients Treated with Trastuzumab in Adjuvant Setting.
Adamczyk A, Grela-Wojewoda A, Domagała-Haduch M, Ambicka A, Harazin-Lechowska A, Janecka A, Cedrych I, Majchrzyk K, Kruczak A, Ryś J, Niemiec J. Adamczyk A, et al. J Cancer. 2017 Jan 1;8(1):131-139. doi: 10.7150/jca.16239. eCollection 2017. J Cancer. 2017. PMID: 28123607 Free PMC article.
Relationship between HER2 gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment.
Adamczyk A, Kruczak A, Harazin-Lechowska A, Ambicka A, Grela-Wojewoda A, Domagała-Haduch M, Janecka-Widła A, Majchrzyk K, Cichocka A, Ryś J, Niemiec J. Adamczyk A, et al. Among authors: harazin lechowska a. Onco Targets Ther. 2018 Aug 3;11:4525-4535. doi: 10.2147/OTT.S166983. eCollection 2018. Onco Targets Ther. 2018. PMID: 30122944 Free PMC article.
26 results